CleveMed’s NeuroSense line is undergoing testing in the U.S. and Europe and is awaiting clearance for sale in both locations, according to the report. It is still developing its seizure detection products.
Read the Crain’s report about CleveMed’s license agreement with NeuroWave.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
